Skip to content

The efficacy of topical castor oil in the treatment of dark circles

The efficacy of topical castor oil in the treatment of dark circles: a non-randomized uncontrolled clinical trial

Status
Recruiting
Phases
Phase 2
Study type
Interventional
Source
IRCT
Registry ID
IRCT20150825023753N16
Enrollment
15
Registered
2020-10-18
Start date
2020-10-22
Completion date
Unknown
Last updated
2020-11-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dark circles under eyes. Chloasma of eyelid and periocular area

Interventions

Intervention group: Participants in this study receive a cream formulation of castor oil 50% prepared at Shiraz School of Pharmacy. The dose of medication is twice a day for two months..

Sponsors

Shiraz University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Age over 18 years Existence of dark circles under the eyes that are not caused by systemic and vascular disease Approved by a dermatologist

Exclusion criteria

Exclusion criteria: Patients with systemic diseases such as diabetes, hyperlipidemia, as well as liver, kidney and thyroid diseases Patents with other dermatological conditions Use of any systemic medication 75/5000Use any other topical medication to remove dark circles under the eyes for at least the past month Hypersensitivity reaction to castor oil Pregnant and lactating women Dissatisfaction with participating in the study

Design outcomes

Primary

MeasureTime frame
The level of darkness of dark circles. Timepoint: The level of darkness is measured at the beginning of the study, then one month and two months later. Method of measurement: Using Visioface 1000D.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr. Mohammad Mahdi Parvizi

Shiraz University of Medical Sciences

mmparvizi@gmail.com+98 71 3212 5592

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026